TP53 and neoplasm: In xenograft murine prostate cancer models obtained using various human prostate cell lines or mouse MPC3 cells harboring double loss of the PTEN and p53 tumor suppressors, knockdown of MAO-A mitigated tumor cell proliferation [33].